Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Fibromyalgia often runs in families because it is polygenic, meaning many common gene variants, each with a small effect, add up to raise your overall risk rather than one single inherited gene causing it. Recent twin and family studies suggest roughly half of the risk comes from genetics, with first-degree relatives of someone with fibromyalgia showing a notably higher likelihood of developing widespread pain themselves. Researchers have linked candidate genes involved in pain signaling, neurotransmitter processing, and stress response to increased sensitivity, though environmental triggers such as infection, injury, or prolonged stress usually determine whether that inherited susceptibility turns into symptoms. Shared family patterns can also reflect overlapping conditions like irritable bowel syndrome, migraine, and chronic fatigue, which complicates the picture in important ways. There are several factors to consider, including which relatives are affected and how symptoms first appeared, so see below to understand more.
If you have widespread pain, unrefreshing sleep, brain fog, or a family history of similar complaints, guessing at the cause can delay relief for years, since fibromyalgia is diagnosed clinically and often only after other conditions are ruled out. A free, instant, online symptom check can help you organize what you are feeling, see which possible causes fit your pattern, and walk into your next appointment with clear, specific information that helps your clinician act faster.
Last reviewed for medical accuracy: 08/18/2026
Fibromyalgia is a chronic pain condition that affects millions worldwide. Although the exact cause remains unclear, recent science points to a polygenic risk—meaning many genes each contribute a small amount to overall susceptibility. When fibromyalgia appears more often in certain families, this reflects the hereditary genetic transmission of fibromyalgia combined with shared environmental factors. Below, we unpack how genes and family patterns intersect, based on credible research.
Polygenic risk means:
Studies show that first-degree relatives (parents, siblings, children) of someone with fibromyalgia are up to three times more likely to develop it than the general population. Why?
Shared Genes
Shared Environment
Gene-Environment Interaction
Researchers have linked fibromyalgia risk to variants in genes that regulate:
Neurotransmission
• Serotonin and dopamine pathways modulate pain perception and mood.
• Variants in SLC6A4 (serotonin transporter) and COMT (enzyme affecting dopamine) appear more often in people with fibromyalgia.
Pain Signaling
• TRPV1, SCN9A and other channels that control nerve excitability.
• Altered function may lead to heightened sensitivity to pain.
Stress and Hormone Regulation
• Variants in the HPA axis (hypothalamic-pituitary-adrenal) can influence cortisol levels and how the body handles stress.
• Poor stress regulation may intensify pain and fatigue.
Immune and Inflammatory Response
• Genes like IL6 and TNF may tweak inflammatory signaling.
• Low-level inflammation could interact with nerve pathways, sustaining chronic pain.
When multiple relatives have fibromyalgia, it’s not random. The pattern emerges from:
Combination of Small Genetic Effects
Every family member inherits a slightly different mix of risk variants. Those who inherit more of them, plus experience certain triggers, are more likely to develop symptoms.
Shared Lifestyle and Coping
How a family responds to stress, illness, or sleep disruption shapes symptom development. For instance, families that normalize high pain tolerance might delay seeking care until symptoms become severe.
Awareness and Diagnosis
If fibromyalgia is recognized in one family member, others may be more likely to notice symptoms in themselves and pursue a diagnosis.
Twin Studies
Genome-Wide Association Studies (GWAS)
Polygenic Risk Scores (PRS)
Understanding the hereditary genetic transmission of fibromyalgia can be empowering rather than frightening:
If you or a loved one experiences persistent, widespread pain, fatigue, or sleep disturbance, consider:
Always speak to a doctor about anything that could be life-threatening or seriously impact daily life. Early intervention can make a big difference in quality of life.
As science advances, we may see:
By staying informed and proactive, you can navigate fibromyalgia risk with greater confidence and control.
(References)
* Colladdo A, de Santos P. [Fibromyalgia: understanding the disease and its social implications]. Rev Esp Anestesiol Reanim. 2006 Jan;53(1):1-3. PMID: 16475632.
* Jonas C. [Fibromyalgia: rheumatologic or psychiatric disease?]. Presse Med. 2006 Nov;35(11 Pt 2):1679-1680. doi: 10.1016/S0755-4982(06)74879-5. PMID: 17086124.
* Bradley LA. Pathophysiology of fibromyalgia. Am J Med. 2009 Dec;122(12 Suppl):S22-30. doi: 10.1016/j.amjmed.2009.09.008. PMID: 19962493; PMCID: PMC2821819.
* Oren O, Ablin JN. Lighting up the genetic understanding of fibromyalgia. J Rheumatol. 2013 Mar;40(3):214-5. doi: 10.3899/jrheum.121411. PMID: 23457397.
* Casale R, Sarzi-Puttini P, Botto R, Alciati A, Batticciotto A, Marotto D, Torta R. Fibromyalgia and the concept of resilience. Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):105-113. Epub 2019 Feb 8. PMID: 30747098.
* Oaklander AL, Nolano M. Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review. JAMA Neurol. 2019 Oct 1;76(10):1240-1251. doi: 10.1001/jamaneurol.2019.2917. PMID: 31498378; PMCID: PMC10021074.
* Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int J Mol Sci. 2021 Apr 9;22(8). doi: 10.3390/ijms22083891. Epub 2021 Apr 9. PMID: 33918736; PMCID: PMC8068842.
* Gyorfi M, Rupp A, Abd-Elsayed A. Fibromyalgia Pathophysiology. Biomedicines. 2022 Nov 29;10(12). doi: 10.3390/biomedicines10123070. Epub 2022 Nov 29. PMID: 36551826; PMCID: PMC9776089.
* Clauw D, Sarzi-Puttini P, Pellegrino G, Shoenfeld Y. Is fibromyalgia an autoimmune disorder? Autoimmun Rev. 2024 Jan;23(1):103424. doi: 10.1016/j.autrev.2023.103424. Epub 2023 Aug 25. PMID: 37634681.
* Kerrebijn I, Bjornsdottir G, Arbabi K, Urpa L, Haapaniemi H, Thorleifsson G, Stefansdottir L, Frangakis S, Valliere J, Kunorozva L, Abner E, Ji C, Aagaard B, Bliddal H, Brunak S, Bruun MT, Didriksen M, Erikstrup C, Geirsson AJ, Gudbjartsson DF, Hansen TF, Jonsdottir I, Knight S, Knowlton KU, Mikkelsen C, Nadauld LD, Olafsdottir TA, Ostrowski SR, Pedersen OB, Saevarsdottir S, Skuladottir AT, Sørensen E, Stefansson H, Sulem P, Sveinsson OA, Thorlacius GE, Thorsteinsdottir U, Ullum H, Vikingsson A, Werge TM, Chronic Pain Genomics Consortium, FinnGen, DBDS Genomic Consortium, Estonian Biobank Research Team, Genes & Health Research Team, Saxena R, Stefansson K, Brummett CM, Glintborg B, Clauw DJ, Thorgeirsson TE, Williams FM, Sinnott-Armstrong N, Ollila HM, Wainberg M. The genetic architecture of fibromyalgia across 2.5 million individuals. medRxiv. 2025 Sep 19. doi: 10.1101/2025.09.18.25335914. Epub 2025 Sep 19. PMID: 41001472; PMCID: PMC12458511.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.